NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class ...

Two Presentations at ASH 2025 to highlight preclinical data and clinical development plans for GB3226, a novel dual ENL-YEATS and FLT3 inhibitor ...

Lawsuit accuses NZXT and partner Fragile Inc. of misleading advertising and deceptive leasing terms • Customers claim ...

Three posters to be presented featuring pre-clinical data of potential best-in-class FGFR3 selective inhibitor, SMARCA2 selective inhibitor, and P53 Y220C reactivatorCandidates for FGFR3 and SMARCA2 ...

Cancer cells frequently express PD-L1 protein to evade immune attack. When PD-L1 on a tumor cell surface binds to PD-1 on a T cell, the T cell becomes inactivated and loses its ability to destroy the ...

Can you show us on the doll where education hurt you?  According to the Right, schools and colleges are hotbeds of ...

The United States government is in the grips of one of its longest-running funding gaps in history. The ongoing government shutdown has already stretched ...

Manhattan Genomics is advancing next-generation medical technologies to correct harmful mutations at the embryonic stage. The company's singular mission is to prevent severe inherited conditions, such ...

Apple today announced financial results for the fourth fiscal quarter of 2025, which corresponds to the third calendar ...